These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 838238)

  • 1. Chemical and biological properties of porcine secretin and secretin analogues modified in positions 3 and 4.
    König W; Geiger R; Wissmann H; Bickel M; Obermeier R; Teetz W; Uhmann R
    Gastroenterology; 1977 Apr; 72(4 Pt.2):797-800. PubMed ID: 838238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological and immunochemical properties of analogues of secretin and vasoactive intestinal peptide (VIP): the vasectrins.
    Beyerman HC; Buijen van Weelderen AW; Chang TM; Chey WY; Grossman MI; Kranenburg P; Scratcherd T; Solomon TE; Voskamp D
    Life Sci; 1981 Aug; 29(9):895-902. PubMed ID: 7300581
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of phenolic group containing analogues of porcine secretin and their immunological properties.
    Yanaihara N; Kubota M; Sakagami M; Sato H; Mochizuki T
    J Med Chem; 1977 May; 20(5):648-55. PubMed ID: 853504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The solid phase synthesis of porcine secretin with full biological activity.
    Hemmasi B; Bayer E
    Int J Pept Protein Res; 1977 Jan; 9(1):63-70. PubMed ID: 838532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of biologically active porcine secretin and [ITyr10] porcine secretin.
    Kofod H
    Int J Pept Protein Res; 1991 Mar; 37(3):185-90. PubMed ID: 1651289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological aspects of secretin, substance P, and VIP.
    Yanaihara N; Sakagami M; Sato H; Yammamoto K; Hashimoto T
    Gastroenterology; 1977 Apr; 72(4 Pt.2):803-10. PubMed ID: 838240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of capillary electrophoresis in drug quality assessment of synthetic porcine secretin.
    Moumakwa BA; Crawley CD; Purich E; Edinboro L; Karnes HT
    Biomed Chromatogr; 2005 Jan; 19(1):68-79. PubMed ID: 15372508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side products in the synthesis of secretin.
    Wünsch E; Bovermann G; Göhring W; Peters B; Scharf R
    Biol Chem Hoppe Seyler; 1990 Mar; 371(3):223-9. PubMed ID: 2340106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogues and fragments of secretin.
    König W; Bickel M; Karch K; Teetz V; Uhmann R
    Peptides; 1984; 5(2):189-93. PubMed ID: 6473152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological potency and chromatographic properties of [aspartoyl3]-secretin, [beta-Asp3]-secretin, and secretin (4-27). Products of intramolecular reactions in secretin.
    Voskamp D; Beyerman HC
    Int J Pept Protein Res; 1981 Sep; 18(3):284-8. PubMed ID: 7341521
    [No Abstract]   [Full Text] [Related]  

  • 11. New analogues of secretin.
    König W; Bickel M; Wissmann H; Sandow J
    Peptides; 1986; 7 Suppl 1():61-7. PubMed ID: 3092198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proform of secretin with high secretin-like bioactivity.
    Gafvelin G; Carlquist M; Mutt V
    FEBS Lett; 1985 May; 184(2):347-52. PubMed ID: 3996590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative synthesis of porcine secretin and apparent autolysis of the product.
    Kiyama S; Kitagawa K; Akita T; Chey WY; Ayalp A; Otsuki A; Funakoshi S; Fujii N; Yajima H
    Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3205-17. PubMed ID: 4085066
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of protected secretin 16-27 on a Merrifield resin. Examination of ammonolysis conditions for preparing carboxamide terminal protected peptides suitable for fragment condensation.
    Wright DE; Agarwal NS; Hruby VJ
    Int J Pept Protein Res; 1980 Mar; 15(3):271-8. PubMed ID: 7380611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on secretin. III. Purification of porcine secretin by high performance liquid chromatography and comparison of the product with synthetic secretin.
    Uchiyama M; Sato T; Yoshino H; Tsuchiya Y; Tsuda T; Kawashima H; Nakatani T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2006-10. PubMed ID: 4053224
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of some polar amino acid residues in secretin.
    Bodanszky M; Fink ML; Boden G
    Gastroenterology; 1977 Apr; 72(4 Pt.2):801-2. PubMed ID: 838239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological potency and stability of native and synthetic secretins.
    Boden G; Dinoso VP; Owen OE
    Gastroenterology; 1974 Dec; 67(6):1119-25. PubMed ID: 4430424
    [No Abstract]   [Full Text] [Related]  

  • 18. Secretin treatment for autism.
    Said SI; Bodanszky M
    N Engl J Med; 2000 Apr; 342(16):1217-8. PubMed ID: 10777379
    [No Abstract]   [Full Text] [Related]  

  • 19. [Structure-functional organization of the secretin molecule. III. Reverse conformation problem].
    Popov EM; Agaeva GA; Akhmedov NA
    Mol Biol (Mosk); 1987; 21(1):182-8. PubMed ID: 3574303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate-like peptides. Part XII. Synthesis and some biological properties of Met-enkephalin analogues modified in position 2 by D-alanyl residue in positions 2 and 4 by 3-(2-naphthyl)-D-alanyl residue.
    Rolka K; Obuchowicz E; Kupryszewski G; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1989; 41(2):147-56. PubMed ID: 2594580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.